Lifecore Biomedical Inc. (LFCR) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Lifecore Biomedical Inc.

    NASDAQ: LFCR · Real-Time Price · USD
    7.53
    -0.41 (-5.16%)
    At close: Sep 05, 2025, 3:59 PM
    7.53
    0.00%
    After-hours: Sep 05, 2025, 04:10 PM EDT

    Lifecore Biomedical Income Statement

    Financials in USD. Fiscal year is June - May.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending May 25, 2025 May 26, 2024 May 28, 2023 May 29, 2022 May 31, 2021
    Revenue
    		 128.87M 128.26M 103.27M 111.27M 100.87M
    Cost of Revenue
    		 88.57M 86.41M 75.98M 135.23M 462.69M
    Gross Profit
    		 40.3M 41.85M 27.98M 39.07M 38.94M
    Operating Income
    		 -38.72M -8.84M -21.8M -11.79M 5.39M
    Interest Income
    		 n/a n/a 68K 81K 48K
    Pretax Income
    		 -38.67M 9.51M -63.93M -20.69M -29.79M
    Net Income
    		 -38.72M 12.01M -99.56M -116.72M -32.66M
    Selling & General & Admin
    		 44.05M 40.46M 43.02M 42.63M 65.36M
    Research & Development
    		 8.26M 8.57M 8.24M 7.84M 10.22M
    Other Expenses
    		 n/a 1.66M -1.48M 385K -27.83M
    Operating Expenses
    		 52.3M 50.69M 49.78M 50.86M 47.76M
    Interest Expense
    		 21.84M 18.09M 17.65M 15.55M 8.93M
    Selling & Marketing Expenses
    		 n/a n/a 5.1K 200K 100K
    Cost & Expenses
    		 140.87M 137.1M 125.06M 123.06M 109.7M
    Income Tax Expense
    		 43K 183K 308K -5.21M -6.35M
    Shares Outstanding (Basic)
    		 34.82M 30.47M 29.96M 29.47M 29.29M
    Shares Outstanding (Diluted)
    		 34.82M 36.66M 29.96M 29.47M 29.29M
    EPS (Basic)
    		 -1.27 0.39 -3.32 -3.97 -1.12
    EPS (Diluted)
    		 -1.27 0.33 -3.32 -3.97 -1.12
    EBITDA
    		 -38.72M 35.6M -35.98M 14.23M 7.52M
    EBIT
    		 -16.84M 27.6M -46.28M -3.43M -1.08M
    Depreciation & Amortization
    		 8.03M 8M 10.3M 17.66M 8.61M

    Add to Watchlist